These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 26182507

  • 1. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L, Yaping L, Xiufen H.
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [Abstract] [Full Text] [Related]

  • 2. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY, Du JB, Chen YH, Li WZ.
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [Abstract] [Full Text] [Related]

  • 3. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
    Song HB, Zhang YD, Dong QW, Han LP, Qi RF, Bi BB, Ma L, Ma L, Zhang H.
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930
    [Abstract] [Full Text] [Related]

  • 4. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 5. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Jul; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease].
    Chen TT, Shi K, Liu YL, Guo YH, Li Y, Wang XM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324
    [Abstract] [Full Text] [Related]

  • 7. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
    Rodríguez-González M, Castellano-Martínez A, Alonso-Ojembarrena A.
    Emergencias; 2016 Apr; 31(2):111-114. PubMed ID: 30963739
    [Abstract] [Full Text] [Related]

  • 9. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY, He T, Ling JY, Hu XF, Wen Y, Wei J, Lu HL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
    [Abstract] [Full Text] [Related]

  • 10. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH.
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [Abstract] [Full Text] [Related]

  • 11. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [Abstract] [Full Text] [Related]

  • 12. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
    Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S.
    Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793
    [Abstract] [Full Text] [Related]

  • 13. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 14. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
    Feng H, Chai H, Li D, Shi C, Xu Y, Liu Y.
    Altern Ther Health Med; 2024 Jan 21; 30(1):302-306. PubMed ID: 37820655
    [Abstract] [Full Text] [Related]

  • 15. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
    Int J Rheum Dis; 2018 Mar 21; 21(3):746-754. PubMed ID: 29105337
    [Abstract] [Full Text] [Related]

  • 16. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease.
    Bai B, Ya JL, Yan C.
    J Coll Physicians Surg Pak; 2022 Aug 21; 32(8):1037-1041. PubMed ID: 35932129
    [Abstract] [Full Text] [Related]

  • 17. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A, Meloche-Dumas L, Desjardins L, Turgeon J, Saint-Cyr C, Autmizguine J, Spigelblatt L, Fournier A, Dahdah N.
    Pediatr Int; 2017 Mar 21; 59(3):265-270. PubMed ID: 27589358
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
    Ganguly M, Nandi A, Banerjee P, Gupta P, Sarkar SD, Basu S, Pal P.
    Int J Rheum Dis; 2022 Jan 21; 25(1):27-31. PubMed ID: 34750969
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K.
    Eur J Pediatr; 2016 Dec 21; 175(12):1997-2003. PubMed ID: 27798729
    [Abstract] [Full Text] [Related]

  • 20. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, Dallaire F, Cousineau J, Delvin E, Dahdah N.
    Pediatr Int; 2012 Oct 21; 54(5):627-33. PubMed ID: 22414326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.